首页> 美国卫生研究院文献>Diagnostic Pathology >Stromal micropapillary pattern predominant lung adenocarcinoma - a report of two cases
【2h】

Stromal micropapillary pattern predominant lung adenocarcinoma - a report of two cases

机译:间质性微乳头型为主的肺腺癌-附两例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Generally, adenocarcinomas with micropapillary pattern, featuring small papillary tufts lacking a central fibrovascular core, are thought to have poor prognosis. This pattern has been described in various organs. However, tumor cells with micropapillary pattern of lung adenocarcinoma are more often seen to float within alveolar spaces (aerogenous micropapillary pattern, AMP) than in fibrotic stroma like other organs (stromal micropapillary pattern, SMP) and SMP predominant lung adenocarcinoma (SMPPLA) has not been well described yet. We presented two cases of SMPPLA which were found in the last four years. Both the cases showed more than 50% of SMP in the tumor area. The majority of the stromal micropapillary clusters expressed MUC1 and epithelial membrane antigen along the outer surface of cell membrane. On the other hand, connective tissues surrounding stromal micropapillary clusters showed no reactivity for epithelial markers (thyroid transcription factor-1 and cytokeratin) or endothelial marker (D2-40 and CD34). It means clusters of SMP do not exist within air space or lymphatic or vessel lumens. The tumors with SMP often presented lymphatic permeation and vessel invasion, and intriguingly, one of the two cases showed metastasis to the mediastinal lymph node. Additionally, both the cases showed EGFR point mutations of exon 21. These results suggest that SMPPLA might be associated with poor prognosis and effective for EGFR tyrosine kinase inhibitors.
机译:通常,具有微乳头状的腺癌,以缺乏中​​央纤维血管核心的小乳头状簇为特征,被认为预后较差。已经在各种器官中描述了这种模式。然而,与其他器官(间质微乳头状,SMP)和SMP占优势的肺腺癌(SMPPLA)一样,与肺脏间质相比,具有肺微腺型的肺腺癌肿瘤细胞更常漂浮在肺泡间隙(气源性微乳头状,AMP)中已经被很好地描述了。我们介绍了在最近四年中发现的两个SMPPLA案例。两种情况均在肿瘤区域显示出超过50%的SMP。多数间质微乳头簇沿细胞膜的外表面表达MUC1和上皮膜抗原。另一方面,基质微乳头簇周围的结缔组织对上皮标记物(甲状腺转录因子-1和细胞角蛋白)或内皮标记物(D2-40和CD34)没有反应。这意味着SMP簇不存在于空气空间,淋巴或血管腔中。具有SMP的肿瘤常表现为淋巴渗透和血管浸润,有趣的是,这两个病例之一显示出转移至纵隔淋巴结。此外,这两种情况均显示外显子21的EGFR点突变。这些结果表明SMPPLA可能与预后不良有关,并且对EGFR酪氨酸激酶抑制剂有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号